Two Indian conglomerates are looking into setting up operations in the biotech and pharmaceutical industry in Malaysia by end of this year.
Malaysia will be their hub in Southeast Asia if the deals kicks off, said Director General of the Malaysian Investment Development Authority (MIDA), Jalilah Baba.
"Its two huge companies for two big projects. It's definitely for more than $312,000 for both.
"We are seriously negotiating with them, where we have made preliminary offers. So it is in their hands to decide," she told reporters on the sidelines of the bilateral meeting between the Ministry of International Trade and Industry and the Indian Minister of Commerce and Industry here yesterday.
Asked on further details of the two companies, Jalilah declined to give details, saying that they were still in discussions.
Jalilah said the Indian parties have not decided on the locations yet and hoped that they would decide to accept the offer before the scheduled Indian Prime Minister Manmohan Singh's visit to Malaysia end of this year.
"We have brought them all around the country. They have been here many times since the meetings that took place during our Prime Minister's visit to India this year.
"Most likely it will take off and in fact in few months time, I think they would really make a decision," she said.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
